Wolf Myles
CIK: 0001808317
Director
Primary company: Akebia Therapeutics, Inc. (AKBA)
Wolf Myles is a corporate insider at Akebia Therapeutics, Inc. (AKBA) filing SEC Form 4 transactions. 11 transactions. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 53,600 | - | - | 53,600 | 6/10/2025 Filed: 6/11/2025 | Filing → | |
| Award | 35,700 | - | - | 133,381 | 6/10/2025 Filed: 6/11/2025 | Filing → | |
| Award | 45,000 | - | - | 45,000 | 6/6/2024 Filed: 6/10/2024 | Filing → | |
| Award | 30,000 | - | - | 97,681 | 6/6/2024 Filed: 6/10/2024 | Filing → | |
| Award | 45,000 | $0.00 | $0 | 45,000 | 6/6/2023 Filed: 6/8/2023 | Filing → | |
| Award | 30,000 | $0.00 | $0 | 67,681 | 6/6/2023 Filed: 6/8/2023 | Filing → | |
| Award | 20,100 | $0.00 | $0 | 20,100 | 6/8/2022 Filed: 6/9/2022 | Filing → | |
| Award | 13,700 | $0.00 | $0 | 37,681 | 6/8/2022 Filed: 6/9/2022 | Filing → | |
| Award | 20,100 | $0.00 | $0 | 20,100 | 6/2/2021 Filed: 6/3/2021 | Filing → | |
| Award | 13,700 | $0.00 | $0 | 23,981 | 6/2/2021 Filed: 6/3/2021 | Filing → | |
| Award | 80,200 | $0.00 | $0 | 80,200 | 4/6/2020 Filed: 4/7/2020 | Filing → |
Type
Award
Shares
53,600
Price
-
Value
-
Type
Award
Shares
35,700
Price
-
Value
-
Type
Award
Shares
45,000
Price
-
Value
-
Type
Award
Shares
30,000
Price
-
Value
-
Type
Award
Shares
45,000
Price
$0.00
Value
$0
Type
Award
Shares
30,000
Price
$0.00
Value
$0
Type
Award
Shares
20,100
Price
$0.00
Value
$0
Type
Award
Shares
13,700
Price
$0.00
Value
$0
Type
Award
Shares
20,100
Price
$0.00
Value
$0
Type
Award
Shares
13,700
Price
$0.00
Value
$0
Type
Award
Shares
80,200
Price
$0.00
Value
$0
AI Agent
Try asking...